DUAL INHIBITORS OF SIGMA-1 RECEPTOR AND SOLUBLE EPOXIDE HYDROLASE AND THEIR USE IN THE TREATMENT OF PAIN
申请人:[en]UNIVERSITAT DE BARCELONA
公开号:WO2024105234A1
公开(公告)日:2024-05-23
The present invention provides compounds of formula (I) for use in the treatment or prevention of pain. The present invention further provides compounds of formula (I') or (Ibis), as well as pharmaceutical composition comprising thereof. Advantageously, the compounds of formula (I), (I') and (Ibis) show a dual effect, inhibiting the soluble epoxide hydrolase and binding to S1 receptor, two of the targets well-documented as involved in pain. (I)